Maharashtra to divert 3 lakh Covaxin doses for 18 to 44 age group to those above 45 due to shortage

State Health Minister Rajesh Tope also said over five lakh people above 45 years are awaiting the second dose of Covaxin in Maharashtra

Press Trust of India May 11, 2021 18:51:43 IST
Maharashtra to divert 3 lakh Covaxin doses for 18 to 44 age group to those above 45 due to shortage

Representational image. PTI

Mumbai: Amid a shortage of COVID-19 vaccine does, the Maharashtra government on Tuesday decided to divert three lakh vials of Covaxin meant for the 18-44 age group for the use of the people aged 45 years and above.

Speaking to reporters, state Health Minister Rajesh Tope also said more than five lakh people above 45 years are awaiting the second dose for the want of the vaccine.

"Efficacy of the vaccine is largely affected if the second dose is not administered in a stipulated time. To avoid such health crisis, the state government has decided to divert three lakh vials (of Covaxin) purchased for the 18-44 age category for the people above 45 years," Tope said.

He said only 35,000 vials of Covaxin are currently available with the state government for administering the second dose to people above 45 years.

According to the Liberalised Pricing and Accelerated National COVID-19 Vaccination Strategy, COVID-19 vaccination is free at government vaccination centres that receive doses from the Centre for eligible population groups comprising healthcare workers, frontline workers and people above the 45 years of age.

However, states and private hospitals have to procure 50 percent of the vaccines in order to immunise persons in the age group of 18 to 44 years.

Updated Date:

also read

As monkeypox drops in the West, still no vaccines for Africa
World

As monkeypox drops in the West, still no vaccines for Africa

No rich countries have shared vaccines or treatments with Africa, and some experts fear interest may soon evaporate.

Vaccine-resistant new COVID-like virus discovered in Russian bats could infect humans, finds study
India

Vaccine-resistant new COVID-like virus discovered in Russian bats could infect humans, finds study

A team led by researchers at Washington State University, US, found spike proteins from the bat virus, named Khosta-2, can infect human cells and is resistant to both the antibody therapies and blood serum from people vaccinated forS-CoV-2

Over 3.70 crore unutilized COVID-19 vaccine doses still available with States, UTs, says health ministry
India

Over 3.70 crore unutilized COVID-19 vaccine doses still available with States, UTs, says health ministry

In the new phase of the universalization of the COVID-19 vaccination drive, the Union Government will procure and supply (free of cost) 75 per cent of the vaccines being produced by the vaccine manufacturers in the country to States and UTs